GT 2331

Known as: GT-2331 
 

Topic mentions per year

Topic mentions per year

1998-2006
01219982006

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
GT-2331 [(+)-1] is one of the most potent members of a class of chiral drug substances used to regulate the synthesis and release… (More)
Is this relevant?
2006
2006
Histamine H(3) receptor antagonists are potential therapeutic agents for cognitive dysfunction, epilepsy, hypersomnia and obesity… (More)
Is this relevant?
2005
2005
Previously reported pharmacological studies using the imidazole-containing histamine H3 receptor ligands GT-2331 (Cipralisant… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2004
2004
GT-2331 is a potent histamine H(3) antagonist which has entered clinical trials. Efficient multigram syntheses of this compound… (More)
Is this relevant?
2003
2003
Pharmacological blockade of central histamine H3 receptors (H3Rs) enhances cognition in rodents and offers promise for the… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 5
Is this relevant?
2002
2002
Histamine H(3) receptor antagonists have been proposed as potentially useful therapeutic agents for the treatment of several… (More)
Is this relevant?
2002
2002
The selective H(3) receptor agonist (R)-alpha-methylhistamine [(R)-alpha-MeHA] stimulates drinking in the adult rat. In the… (More)
Is this relevant?
1999
1999
Previously, a novel series of 1H-4-substituted imidazole compounds were described as potent and selective histamine (HA) H3… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
1998
1998
GT-2227 (4-(6-cyclohexylhex-cis-3-enyl)imidazole) and GT-2331 ((1R,2R)-4-(2-(5,5-dimethylhex-1-ynyl)cyclopropyl)imidazole) were… (More)
Is this relevant?